NASDAQ: AMLXAmylyx Pharmaceuticals Inc Stock Ownership - Who owns Amylyx Pharmaceuticals?
Insider buying vs selling
Have Amylyx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Justin B. Klee | Co-Chief Executive Officer | 2024-03-05 | 4,135 | $18.73 | $77.44kSell |
| James M. Frates | Chief Financial Officer | 2024-03-05 | 1,792 | $18.73 | $33.56kSell |
| Joshua B. Cohen | Co-Chief Executive Officer | 2024-03-05 | 4,135 | $18.73 | $77.44kSell |
| Gina Mazzariello | Chief Legal Officer | 2024-03-05 | 1,540 | $18.73 | $28.84kSell |
| Gina Mazzariello | Chief Legal Officer | 2024-02-23 | 2,838 | $18.76 | $53.23kSell |
| Patrick D. Yeramian | Chief Medical Officer | 2024-01-09 | 2,812 | $16.33 | $45.91kSell |
| Joshua B. Cohen | Co-Chief Executive Officer | 2024-01-09 | 5,841 | $16.33 | $95.37kSell |
| James M. Frates | Chief Financial Officer | 2024-01-09 | 2,716 | $16.33 | $44.35kSell |
| Justin B. Klee | Co-Chief Executive Officer | 2024-01-09 | 5,841 | $16.33 | $95.37kSell |
| Margaret Olinger | Chief Commercial Officer | 2023-12-27 | 25,000 | $0.37 | $9.25kBuy |
AMLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMLX insiders and whales buy or sell their stock.
AMLX Shareholders
What type of owners hold Amylyx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Morningside Venture Investments Ltd | 38.49% | 26,091,760 | $46.44M | Insider |
| Isaac Cheng | 15.38% | 10,422,228 | $18.55M | Insider |
| Invest 1. Bv Als | 8.70% | 5,895,280 | $10.49M | Insider |
| Vanguard Group Inc | 7.78% | 5,275,566 | $9.39M | Institution |
| Blackrock Inc | 5.90% | 4,002,334 | $7.12M | Institution |
| Joshua B. Cohen | 4.73% | 3,202,852 | $5.70M | Insider |
| Justin B. Klee | 4.63% | 3,139,158 | $5.59M | Insider |
| Viking Global Investors LP | 4.37% | 2,962,555 | $5.27M | Institution |
| Morgan Stanley | 4.18% | 2,830,243 | $5.04M | Institution |
| Point72 Asset Management LP | 4.06% | 2,751,305 | $4.90M | Institution |
AMLX vs Biotech Stocks
Amylyx Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.